RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.17
-0.12 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
7.17
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:29 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $295.88 million as of April 28, 2026. Its market cap has decreased by -48.50% in one year.
Market Cap
295.88M
Enterprise Value
79.20M
1-Year Change
-48.50%
Ranking
Category
Stock Price
$7.17
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $295.88M, a decrease of -30.27%. That is a compound annual growth rate of -7.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 300.83M | -29.78% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OrthoPediatrics | 388.89M |
| Viemed Healthcare | 386.76M |
| Delcath Systems | 363.32M |
| Standard BioTools | 359.80M |
| CapsoVision | 337.91M |
| ClearPoint Neuro | 332.25M |
| Senseonics Holdings | 300.15M |
| TriSalus Life Sciences | 275.75M |